Hims & Hers Health, Inc. faces short-term pressure after missing Novo’s partner list, but lab testing boosts long-term growth ...

Hims & Hers Health, Inc. (NYSE:HIMS) is among the 7 Best Beauty Stocks to Buy Right Now. TheFly reported on January 8, 2026, ...

Hims & Hers Health (HIMS) is back in focus as investors reassess its telehealth model, weighing GLP-1 related interest and ...

Hims & Hers stock has nosedived in the past few months. It has dived by over 56% from its highest point in July last year and ...

Hims & Hers Health, Inc. (HIMS) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look ...

Hims & Hers is down 30% but still a Buy: margin expansion, GLP-1 clarity, new hormone care, and global growth. Learn more ...

Hims & Hers posted record revenue this quarter. It is still selling patented weight loss drugs on its platform and is now getting sued by the pharmaceutical companies. Investors would do best to avoid ...

Hims & Hers Health Stock Slides on Earnings Miss and Soft Guidance: Is $40 the Next Stop? Hims & Hers Health (HIMS) reported Q2 results after the close last night, delivering a mixed set of numbers ...

Hims & Hers Health Inc (NYSE:HIMS) shares fell 3.09% Wednesday morning to $62.02, giving back some of the recent gains following its strong first-quarter earnings report. Despite the pullback, the ...

Detailed price information for American Well Corp Cl A (AMWL-N) from The Globe and Mail including charting and trades.

Based on current trajectories, analysts project that HIMS stock could reach $52 by December 2027, representing a potential 65% return from its current price of $32. The company’s Q3 revenue of $600 ...